New: NCI-funded clinical trial search
Mednet Logo
CommunityPrimary Care

What is your treatment approach for hidradenitis suppurativa?

Do you reserve biologics for more systemic involvement? When do you initiate biologics such as secukinumab?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Dermatology · Wayne State University
Answered on

In HS, we talk about a "window of opportunity." It's the idea that since HS causes tissue damage, scarring, and tunneling, treatment becomes more difficult as the disease progresses. A delay of 10 years between symptom onset and starting adalimumab was associated with a 1.92x higher odds that the pa...

Join for free or sign in to see the full answer